Edition:
United Kingdom

Merit Medical Systems Inc (MMSI.OQ)

MMSI.OQ on NASDAQ Stock Exchange Global Select Market

61.28USD
16 Nov 2018
Change (% chg)

-- (--)
Prev Close
$61.28
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
132,026
52-wk High
$66.28
52-wk Low
$39.05

Summary

Name Age Since Current Position

Fred Lampropoulos

68 1987 Chairman of the Board, President, Chief Executive Officer

Raul Parra

40 2018 Chief Financial Officer

Joseph Wright

48 2015 President - International Division

Ronald Frost

56 2014 Chief Operating Officer

Justin Lampropoulos

2015 Executive Vice President - Sales, Marketing and Strategy

Brian Lloyd

57 2016 Chief Legal Officer, Corporate Secretary

Nolan Karras

73 2017 Lead Independent Director

David Liu

44 2016 Director

A. Scott Anderson

71 2011 Independent Director

Thomas Gunderson

67 2017 Independent Director

Franklin Miller

77 2005 Independent Director

F. Ann Millner

66 2015 Independent Director

Kent Stanger

63 2015 Independent Director

Michael Stillabower

74 1996 Independent Director

Anne-Marie Wright

Vice President - Corporate Communications

Biographies

Name Description

Fred Lampropoulos

Mr. Fred P. Lampropoulos is Chairman of the Board, President, Chief Executive Officer of the Company. He served as Chair of the Board, CEO, and President of the Company since its formation in July 1987. He served asChair of the Board and President of Utah Medical Products, Inc. (medical device manufacturer), 1983 to 1987 and Filed more than 200 domestic and international patents and applications on medical devices. He Serves on several community and advisory boards .He is Recipient of numerous awards, including 2003 Utah Governor’s Medal for Science and Technology. The Board believes the Company benefits immensely from Mr. Lampropoulos’ experience as founder, President and Chief Executive Officer of the Company. He plays an essential role in communicating the expectations, advice, concerns and encouragement of the Board to our employees. Mr. Lampropoulos has a deep knowledge and understanding of the Company, as well as the industry and markets in which our products compete. Mr. Lampropoulos also performs an essential function as the Chair of the Board, providing decisive leadership and direction to the activities and deliberations of the Board. The Board also believes Mr. Lampropoulos’ leadership, drive and determination are significant factors in our growth and development and continue to be tremendous assets to the Company and its shareholders.

Raul Parra

Mr. Raul Parra, Jr. is Chief Financial Officer of the Company. He has served as Vice President of Accounting with the Company since February 2016 and served as Corporate Controller of the Company from July 2012 to January 2015. Mr. Parra served in other accounting-related capacities with the Company, including Director of Financial Reporting, from December 2009 to July 2012. Prior to joining the Company, Mr. Parra was employed as an auditor by Deloitte & Touche LLP from 2003 to 2009. Mr. Parra holds a Bachelor of Science degree in Business Administration, with an emphasis in accounting, from Sonoma State University, which was awarded in 2003. Mr. Parra is a certified public accountant.

Joseph Wright

Mr. Joseph C. Wright is President - International Division of the Company. He is joined the Company in 2005 as Vice President, International, responsible for sales in Canada, Asia Pacific, and Latin America. In 2006. Previous positions at Merit include (a) President, Technology Group – overseeing Merit OEM, Merit Sensor Systems, Inc., and Merit’s coating division, (b) Vice President of Marketing, and (c) Vice President, International – responsible for sales in Canada, Asia Pacific, and Latin America, 2005 to 2015. He Manages businesses in all global markets outside the U.S. and EMEA. Before joining Merit, held sales, marketing and business development positions with several companies, including Motorola and Micron. B.A., (political science), Columbia University; M.B.A., (finance) Columbia University; Speaks Japanese. Mr. Wright is the brother-in-law of Fred P. Lampropoulos, Merit’s CEO, President and Chair of the Board

Ronald Frost

Mr. Ronald A. Frost is Chief Operating Officer of the Company. Prior to his appointment as Chief Operating Officer effective January 1, 2014, Mr. Frost worked for More than 26 years of service to Merit and its shareholders. Previous positions at Merit include Vice President (Materials and Operations), Quality Engineer, Manufacturing Engineer, Custom Kits Manager, Customer Service Manager, Production Planning and Warehouse Manager, General Manager of our Richmond, Virginia operations, and Vice President (Technology Transfer), 1991 to 2014.

Justin Lampropoulos

Mr. Justin J. Lampropoulos is Executive Vice President - Sales, Marketing and Strategy of the company. He began his career in medical device technology as a member of the Company’s sales organization in 2004. Most recently, he spent five years, from 2010 until 2015, leading the Company’s EMEA business unit from Maastricht, The Netherlands before returning to the Company’s headquarters to lead the Company’s commercial organization in addition to global marketing and strategy. Mr. Lampropoulos completed postgraduate studies at Oxford University’s Saïd Business School in Oxford, England in strategic management and is an alumnus of Harvard Business School.

Brian Lloyd

Mr. Brian G. Lloyd is Chief Legal Officer, Corporate Secretary of the Company. Prior to joining the Company, Mr. Lloyd Practiced as an attorney, specializing in corporate governance, securities regulation and mergers and acquisitions, with the law firm of Parr Brown Gee & Loveless in Salt Lake City, Utah for more than 20 years. Also practiced law in those areas of specialization as a partner with the law firm of Stoel Rives, LLP for four years. He holds B.S. (finance), Brigham Young University; J.D., Columbia Law School.

Nolan Karras

Mr. Nolan E. Karras serves as Lead Independent Director of the Company. He was Independent Director of Merit Medical Systems, Inc., since November 5, 2011. Mr. Karras has been engaged as the Chairman and Chief Executive Officer of The Karras Company, Inc., an investment advisory firm, since 1997 and is a certified public accountant. Mr. Karras serves on the board of Western Hay Company, Inc., an agricultural products company located in Ogden, Utah, where he also served as chief executive officer from 1995 to 2012. Mr. Karras was appointed a member of the Board of Trustees of Weber State University in 2013. He is also a member of the Community Board of Directors of University of Utah Hospitals and Clinics, where he serves as Chairman of the Finance Committee. Mr. Karras previously served from 1996 to 2009 on the board of directors of Beneficial Life Insurance Company, a privately-held life insurance company headquartered in Salt Lake City, Utah, where he was chair of the investment committee and a member of the executive committee. In 2013, Mr. Karras completed a 12-year term as a member of the Utah State Board of Regents, where he served as board chairman from 2002 to 2006. Mr. Karras previously served as a director and member of the audit and compensation committees of the boards of directors of PacifiCorp, a public utility operating in the northwestern United States, and Scottish Power, a multinational energy company. Mr. Karras has held several positions in public service, including service in the Utah House of Representatives for ten years where he served as Speaker of the House and House Majority Leader. He holds B.A., Weber State University; M.B.A., University of Utah; Certified Public Accountant

David Liu

Dr. David Ming-Teh Liu is Director of the Company. He is an Interventional Radiologist with the current appointment of Clinical Associate Professor of Radiology at the University of British Columbia, a position he has held since 2008. Dr. Liu Interventional radiologist (certified in the U.S. and Canada), practicing at the Vancouver General Hospital, University of British Columbia Hospital, and BC Cancer Agency (with cross appointment in surgery department), 2008 to present. He is Clinical Associate Professor of Radiology at the University of British Columbia, 2008 to present, Medical Director at Eva Vein Care (team of physicians specializing in diagnostic assessment, endovascular therapy and interventional radiology), 2012 to present, Co-founder and co-chair of the international liver cancer symposium, SHOW, Credited with 7 book chapters, over 60 publications, and 100 invited lectures around the world, Inducted Fellow of the Society of Interventional Radiology. He holds M.D., University of Toronto; Radiology residency at University of British Columbia; Interventional radiology fellowship at Northwestern Memorial Hospital. In addition to bench side and clinical research in the fields of novel embolic platforms, ablative technologies and cancer-related thromboembolic disease, Dr. Liu maintains an interventional oncology practice incorporating multiple aspects of embolization, ablation, venous access, and palliative therapy in organ systems. Fluent in mandarin, Dr. Liu is an active member of the interventional radiology community and has served as an advisor on multiple global advisory boards and technology development committees for various scientific and commercial organizations. The Board believes Dr. Liu’s extensive industry experience, scientific credentials and active clinical practice provide him with vital insights into the trends, risks and opportunities in many of our core interests. Dr. Liu also contributes valuable clinical and industry perspective to the Board’s analysis of prospective acquisitions

A. Scott Anderson

Mr. A. Scott Anderson is Independent Director of the Company. He is the President and Chief Executive Officer of Zions First National Bank, a commercial bank located in the intermountain United States. Mr. Anderson also serves on the Board of Directors of Intermountain Healthcare, an integrated healthcare system located in Utah and Idaho. From 2003 to 2008, Mr. Anderson served as a President and CEO of Zions First National Bank (commercial bank based in the intermountain U.S.), 1998 to present Member of Board of Trustees of Intermountain Healthcare (integrated healthcare system in Utah and Idaho), 2005 to present (Chair, 2012 to present), Director of the Federal Reserve Bank of San Francisco (Salt Lake City Branch), 2003 to 2008. He holds B.A. (philosophy, economics), Columbia University; M.S. (economics, international studies), Johns Hopkins University. Mr. Anderson contributes to the Board’s deliberations more than 40 years of experience in the banking and financial services industries. The Board believes Mr. Anderson provides insight regarding national and international financial and credit markets, as well as lending practices, which are valuable as we continue to implement our growth strategy. Mr. Anderson also contributes extensive business and corporate governance experience to the strategic planning and operational discussions of the Board.

Thomas Gunderson

Mr. Thomas Gunderson serves as Independent Director of the Company. Mr. Gunderson is the Chair of the Board of Directors at the Minneapolis Heart Institute Foundation, 2015 to present ,Executive in Residence at the University of Minnesota’s Medical Industry Leadership Institute, 2016 to present ,Member of American Heart Association Science and Technology Accelerator Committee, 2015 to 2017Managing director and senior research analyst at Piper Jaffray (focus on medical technology companies), 1992 to 2016 ,Project Director at American Medical Systems (private medical device company acquired by Pfizer in 1983), 1979 to 1992 ,Recognized by several industry publications, including the Wall Street Journal, Institutional Investor, First Call, Thomson Reuters, and Medical Device and Diagnostic Industry (e.g., in 1996 and 2000, he was named an All-Star Analyst for medical stocks by the Wall Street Journal and in 2014, Thomson-Reuters named him “Top Stock Picker” in the medical technology sector) . He holds B.A. (biology focus), Carleton College; M.S. (cell biology), University of Minnesota; M.B.A., University of St. Thomas. Mr. Gunderson provides the Board with more than 25 years of substantive experience in the medical device industry, with a seasoned perspective on the challenges, trends and opportunities of publicly-traded medical device manufacturers, as well as a keen understanding of the Company’s competitive position within its industry. Mr. Gunderson also contributes a strong background in financial and economic analysis and valuable insights regarding business development and acquisition opportunities.

Franklin Miller

Dr. Franklin J. Miller is Independent Director of the Company. He retired as a Professor of Radiology and Surgery from the University of Utah, Department of Radiology, in 2005, where he Consultant to the Company, assisting in product testing and development, 1997 to 2005, Professor of Radiology and Surgery at the University of Utah Department of Radiology, 1976 to 2005 (Director of Interventional Radiology, 1976 to 2001), Clinical Professor of Radiology at the University of California, San Diego (began the Hereditary Hemorrhagic Telangiectasia Clinic, one of only eight such clinics in the United States), 2002 to 2011 ,Served on advisory boards to several medical device companies and member of editorial and review boards for numerous medical journals. He holds B.S. (pre-med), Pennsylvania State University; M.D., Temple University Medical School; Resident and fellowship, Johns Hopkins University. Dr. Miller contributes a valuable set of skills, training and experience to the Board’s deliberations. During his service as a director, Dr. Miller has provided significant advice regarding our product development strategy and plays a significant role in our evaluation of acquisition and other growth opportunities. Based, in part, on his extensive medical training and his experience with various medical devices, Dr. Miller provides the Board valuable insight regarding the needs and preferences of the medical professionals who use and purchase our products.

F. Ann Millner

Dr. F. Ann Millner, Ed.D. is Independent Director of the Company. She has served as Regents Professor in Health Administrative Services at Weber State University. Dr. Millner also serves as a member of the Utah State Senate, where she chairs the Senate Education Committee and serves on the Economic Development and Workforce Services and Higher Education Appropriations and Public Education Appropriations Subcommittees. Dr. Millner Regents Professor and Professor of Health Administrative Services at Weber State University, 2013 to present Member of the Utah State Senate (member of multiple committees and subcommittees), 2015 to present Member of Utah Governor’s Task Force on Educational Excellence, 2015 to present ,Member of Board of Trustees of Intermountain Healthcare (integrated healthcare system in Utah and Idaho), 2005 to present (serving as Vice Chair, 2017 to present) ,President of Weber State University, 2002 to 2012 (first female president of a Utah state university) Vice President of University Relations at Weber State University, 1993 to 2002 Associate Dean of Continuing Education and Assistant Vice President of Community Partnerships at Weber State University, 1985 to 1993. She holds .B.S. (education), University of Tennessee; M.S. (allied health education and management), Southwest Texas State University; Ed.D (education administration), Brigham Young University; Completed medical technology program, Vanderbilt University.

Kent Stanger

Mr. Kent W. Stanger is Independent Director of the Company. He is currently engaged in real estate development and private investment management. From 1987 until November 2015, Mr. Stanger served as the Chief Financial Officer, Secretary and Treasurer of the Company. Mr. Stanger has served as director of the Company since 1987. Prior to joining the Company, Mr. Stanger was Member of Board of Directors and Executive Committee of Utah Taxpayers Association, 2012 to 2016 Chief Financial Officer, Secretary and Treasurer of the Company, 1987 to 2015, Controller of Utah Medical Products, Inc. (medical device manufacturer), 1985 to 1987 Corporate Controller for Laser Corporation, American Laser and Modulaire Industries, Inc., 1982 to 1985 Hansen, Barnett and Maxwell (former Utah accounting firm that merged with Eide Bailly LLP in 2013) as practicing certified public accountant, 1979 to 1982. He holds B.A. (accounting), Weber State University; former Certified Public Accountant. Mr. Stanger was a founder of the Company and, through more than 25 years of service as the principal financial manager of the Company, developed a broad understanding of our business and operations, as well as the industry and markets in which the Company competes. The Board values Mr. Stanger’s accounting and financial management skills and benefits greatly from his extensive knowledge of our history, achievements, competitive position and strategic objectives.

Michael Stillabower

Dr. Michael E. Stillabower, M.D. is Independent Director of the company. He has been a physician in private practice in Wilmington, Delaware since 1980. In 1999, Dr. Stillabower is Director of Cardiovascular Clinical Trials at Christiana Care Health Systems, 1999 to 2014, Chief of Cardiology at Medical Center of Delaware, 1988 to 1999 (director of coronary care unit, 1984 to 1988), Clinical Associate Professor of Medicine, Sidney Kimmel Medical College, 1995 to present , Elected Fellow of the American College of Cardiology and a member of other professional associations and is actively engaged in cardiology research, instruction and publication of related papers and abstracts. He holds B.S. in electrical engineering, Purdue University; M.D., Sidney Kimmel Medical College; Residency, Wilmington Medical Center; Fellowship, Washington D.C. VA Medical Center. Dr. Stillabower’s service reflects the Board’s recognition of his expertise in the medical profession, his valuable role in developing and evaluating existing and proposed Company products and his understanding of the medical community and the markets for our products. Dr. Stillabower contributes more than 30 years of specialized training and experience in cardiology and related fields to the Board, and has actively participated in the development and commercialization of many of our products. He has used our products in cardiac procedures and provides valuable insights from a practitioner’s viewpoint.

Anne-Marie Wright

Basic Compensation